Losartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Date: July 16, 2014
Price:
US$ 600.00
Publisher: Ark Patent Intelligence
Report type: Periodicals
Delivery: E-mail Delivery (PDF)
ID: LB422104E30EN
Leaflet:

Download PDF Leaflet

Losartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
Please note that this publication is updated montly

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

“The most extensive source of patent information available.' Product Portfolio Manager - Dr Reddys Laboratories

“The database is reliable, frequently updated, well-arranged, user friendly.” Director IP - Zentiva k.s

“Allows me to perform an analysis on an INN in hours rather than days”. IP Council, top 10 generics company

WATERTIGHT, USER-FRIENDLY DATA YOU CAN RELY ON
  • Key patent, extension and data exclusivity expiry in one simple view
  • Highly accurate, manually verified data
  • Full consideration of paediatric, orphan and complex data exclusivity
INSIGHT AND UNDERSTANDING FOR ALL LEVELS OF EXPERTISE
  • Patents interpreted and assigned to categories
  • Expert constraint analysis, commentary, and SPC validity flags
  • Flags indicate constraining, difficult or nuisance patents
  • Available on a per molecule basis
SAVE VAST AMOUNTS OF TIME
  • Complete, reliable and verifiable data so you don’t have to fill holes and double check
  • Intelligent, friendly design means fewer clicks and quicker understanding
  • Hyperlinking to vital patent documentation allows fast analysis and verification
  • Add your own notes, save searches and results
THIS REPORT COVERS:

International Nonproprietary Name:
Losartan
indications:
Hypertension; Diabetic nephropathy
innovator:
Merck (Cozaar)

COUNTRY COVERAGE:
  • Australia
  • Canada
  • France
  • Germany
  • Great Britain
  • Italy
  • Japan
  • Spain
  • USA
Please note that 50 country coverage is also available.

ACCESS:

This report is provided through an online portal for a period of 12 months, for a maximum of 5 users. During this period, access to updates, excel exports, patent documents and national registers is provided at no additional charge.

ABOUT GENERICSWEB:

Patent, Extension and Data Exclusivity Expiry Snapshot is just one of the benchmark products from Ark Patent Intelligence's product suite from GenericsWeb. Established in 1999, GenericsWeb has customers in over 40 countries including generic and innovator pharmaceutical manufacturers, legal practices, consultants and government departments. Ark Patent Intelligence provides the most comprehensive, relevant and accurate patent information available, stemming from 100% dedication to the industry, extensive experience and investment in customer research and product development.
Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know.

WATERTIGHT, USER-FRIENDLY DATA YOU CAN RELY ON
  • Key patent, extension and data exclusivity expiry in one simple view
  • Highly accurate, manually verified data
  • Full consideration of paediatric, orphan and complex data exclusivity
INSIGHT AND UNDERSTANDING FOR ALL LEVELS OF EXPERTISE
  • Patents interpreted and assigned to categories
  • Expert constraint analysis, commentary, and SPC validity flags
  • Flags indicate constraining, difficult or nuisance patents
  • Available on a per molecule basis
SAVE VAST AMOUNTS OF TIME
  • Complete, reliable and verifiable data so you don’t have to fill holes and double check
  • Intelligent, friendly design means fewer clicks and quicker understanding
  • Hyperlinking to vital patent documentation allows fast analysis and verification
  • Add your own notes, save searches and results

Ask Your Question

Losartan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: